Did Covid 19 disease increase mesenteric ischemia cases?

Hüsnü Çağrı Genç, K. Gemici
{"title":"Did Covid 19 disease increase mesenteric ischemia cases?","authors":"Hüsnü Çağrı Genç, K. Gemici","doi":"10.7197/cmj.1278581","DOIUrl":null,"url":null,"abstract":"İntroduction \nCovid 19 (C19) disease causes mortal complications due to both respiratory system involvement and extrapulmonary involvement. C19 patients may present with gastrointestinal symptoms such as nausea-vomiting, diarrhea and loss of appetite, as well as serious conditions such as acute mesenteric ischemia. C19 disease is a proinflammatory condition that causes thrombus formation. \nMaterial method \nThe first group (G1) was treated with 21 mesenteric ischemia cases operated in the General Surgery Department of Aksaray Training and Research Hospital in approximately two years between March 2020 and February 2022, and the second group (G2), in a two-year period between 2018-2020 before the pandemic, in the same department. The information of 11 mesenteric ischemia cases who underwent surgery were analyzed from the hospital information system. Statistically, the predisposing diseases, demographic data, intestinal lengths removed during the operation, and survival of the patients in both groups were compared. \nResults \nWhen the number of patients who were operated on in G1 and G2 were compared, it was seen that more patients were operated in G1. The probability of mesenteric ischemia in a 24-month period was found to be 0.875 in G1 and 0.458 in G2. These rates were statistically different (p=0.002). When the mean age, length of the removed bowel, and postoperative mortality of both groups were compared, no significant difference was found. \nConclusion \nAlthough the exact mechanism by which the Covid 19 disease causes mesenteric ischemia is not understood, we observed a statistically significant increase in mesenteric ischemia cases during the pandemic period compared to the pre-pandemic return. Considering the Physiopathology of C19, it is known that the diseases in the body generally occur on the basis of vasculitis. When C19 infection is detected, we recommend anticoagulant treatment for at least 3 months during the infection and for the prevention of other complications related to vasculitis, especially mesenteric ischemia.","PeriodicalId":10750,"journal":{"name":"Cumhuriyet medical journal","volume":"64 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cumhuriyet medical journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7197/cmj.1278581","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

İntroduction Covid 19 (C19) disease causes mortal complications due to both respiratory system involvement and extrapulmonary involvement. C19 patients may present with gastrointestinal symptoms such as nausea-vomiting, diarrhea and loss of appetite, as well as serious conditions such as acute mesenteric ischemia. C19 disease is a proinflammatory condition that causes thrombus formation. Material method The first group (G1) was treated with 21 mesenteric ischemia cases operated in the General Surgery Department of Aksaray Training and Research Hospital in approximately two years between March 2020 and February 2022, and the second group (G2), in a two-year period between 2018-2020 before the pandemic, in the same department. The information of 11 mesenteric ischemia cases who underwent surgery were analyzed from the hospital information system. Statistically, the predisposing diseases, demographic data, intestinal lengths removed during the operation, and survival of the patients in both groups were compared. Results When the number of patients who were operated on in G1 and G2 were compared, it was seen that more patients were operated in G1. The probability of mesenteric ischemia in a 24-month period was found to be 0.875 in G1 and 0.458 in G2. These rates were statistically different (p=0.002). When the mean age, length of the removed bowel, and postoperative mortality of both groups were compared, no significant difference was found. Conclusion Although the exact mechanism by which the Covid 19 disease causes mesenteric ischemia is not understood, we observed a statistically significant increase in mesenteric ischemia cases during the pandemic period compared to the pre-pandemic return. Considering the Physiopathology of C19, it is known that the diseases in the body generally occur on the basis of vasculitis. When C19 infection is detected, we recommend anticoagulant treatment for at least 3 months during the infection and for the prevention of other complications related to vasculitis, especially mesenteric ischemia.
新冠肺炎是否增加了肠系膜缺血病例?
İntroduction Covid - 19 (C19)疾病由于呼吸系统受累和肺外受累而导致致命并发症。C19患者可能出现恶心呕吐、腹泻和食欲不振等胃肠道症状,也可能出现急性肠系膜缺血等严重情况。C19疾病是一种引起血栓形成的促炎性疾病。第一组(G1)于2020年3月至2022年2月在阿克萨莱培训与研究医院普外科手术治疗的肠系膜缺血患者21例,第二组(G2)于大流行前的2018-2020年在同一科手术治疗。分析医院信息系统中11例肠系膜缺血手术患者的信息。统计学上比较两组患者的易感疾病、人口学资料、术中切除的肠长及生存率。结果比较G1期和G2期手术患者的数量,G1期手术患者较多。在24个月的时间内,G1发生肠系膜缺血的概率为0.875,G2为0.458。这些比率有统计学差异(p=0.002)。比较两组患者的平均年龄、切除肠段长度和术后死亡率,无显著差异。结论虽然Covid - 19疾病引起肠系膜缺血的确切机制尚不清楚,但我们观察到,与大流行前相比,大流行期间肠系膜缺血病例有统计学意义的增加。考虑到C19的生理病理,我们知道体内的疾病一般是在血管炎的基础上发生的。当检测到C19感染时,我们建议在感染期间至少进行3个月的抗凝治疗,并预防与血管炎相关的其他并发症,特别是肠系膜缺血。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信